Home/PEP-Therapy/Laura Dadon, PharmD

LD

Laura Dadon, PharmD

Head of Drug Development

Therapeutic Areas

PEP-Therapy Pipeline

Drug	Indication	Phase
PEP-010	Recurrent and/or metastatic solid tumors (including pancreatic cancer)	Phase 1a/b

Leadership Team at PEP-Therapy

Antoine Prestat

Co-founder and CEO

Jennifer Sengenès, PhD

Head of Strategy and Development

Hatem Azim, MD, PhD

Chief Medical Officer

Diego Germini, PhD

Head of Research

View full PEP-Therapy profile